LabCorp Acquires Covance Genomics Laboratory
LabCorp has acquired Covance Genomics Laboratory and its associated genomic analysis business.
LabCorp has acquired Covance Genomics Laboratory and its associated genomic analysis business. The laboratory is located in Seattle and provides complex genomic analysis, including gene expression array studies and next generation sequencing applications. As part of the acquisition, LabCorp and Covance have entered into a five-year services agreement to collaborate and continue offering specialty genomic services to Covance clients. The existing 50 employees, both scientists and staff, are now LabCorp employees.
Read the full release here.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs. 2.4 mg, Placebo
January 17th 2025Semaglutide 7.2 mg significantly outperformed semaglutide 2.4 mg and placebo with a 20.7% average reduction in weight and a comparable safety and tolerability profile, further establishing its efficacy in obesity treatment.
